Interpace Biosciences (IDXG) Revenue
Market Cap: $8.83M
Avg Volume: 7.93K
Industry: Medical - Diagnostics & Research
Sector: Healthcare
What is Interpace Biosciences's Revenue?
Interpace Biosciences's quarterly revenue as of Q2 2024 is $12.04M.
Interpace Biosciences's annual revenue for the fiscal year 2023 is $40.21M.
Related metrics for Interpace Biosciences (quarterly):
- Cost of Revenue: $4.61M
- Gross Profit: $7.43M
- Gross Profit Ratio: 61.71%
- Revenue Per Share: $2.75
- Revenue Growth: 17.22%
Apple's quarterly revenue was $12.04M, with a cost of revenue of $4.61M, which leaves $7.43M gross profit and a gross profit ratio of 61.71%.
Related metrics for Interpace Biosciences (annual):
- Cost of Revenue: $17.17M
- Gross Profit: $23.04M
- Gross Profit Ratio: 57.30%
- Revenue Per Share: $9.32
- Revenue Growth: 26.31%
Apple's annual revenue was $40.21M, with a cost of revenue of $17.17M, which leaves $23.04M gross profit and a gross profit ratio of 57.30%.
Understanding Revenue
Revenue is the total amount of income generated by the sale of goods or services related to the company's primary operations. It is often referred to as the "top line" because it sits at the top of the income statement.
Note: The historical revenue chart displays quarterly revenue data.
Note: The revenue growth chart displays annual growth percentages.
Note: The revenue per share chart displays revenue per share data.
End of Year Revenue
The table below shows the revenue for each fiscal year, with the latest data available for 2023.
| Year | Revenue | Change |
|---|---|---|
| 2023 | $40.21M | 26.31% |
| 2022 | $31.84M | -22.94% |
| 2021 | $41.31M | 27.52% |
| 2020 | $32.40M | 34.55% |
| 2019 | $24.08M | 9.97% |
| 2018 | $21.90M | 37.74% |
| 2017 | $15.90M | 21.49% |
| 2016 | $13.09M | 38.73% |
| 2015 | $9.43M | -92.14% |
| 2014 | $119.94M | -20.49% |
| 2013 | $150.84M | 18.87% |
| 2012 | $126.90M | -19.32% |
| 2011 | $157.29M | 8.74% |
| 2010 | $144.65M | 70.44% |
| 2009 | $84.87M | -24.58% |
| 2008 | $112.53M | -3.93% |
| 2007 | $117.13M | -51.04% |
| 2006 | $239.24M | -25.10% |
| 2005 | $319.42M | -12.36% |
| 2004 | $364.44M | 14.80% |
| 2003 | $317.45M | 11.77% |
| 2002 | $284.01M | -59.23% |
| 2001 | $696.58M | 67.10% |
| 2000 | $416.88M | 138.35% |
| 1999 | $174.90M | 73.00% |
| 1998 | $101.10M | 84.83% |
| 1997 | $54.70M | N/A |